We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Increased Breast Cancer Driving Global Digital Breast Tomosynthesis Market

By HospiMedica International staff writers
Posted on 31 Dec 2018
The global digital breast tomosynthesis market is expected to grow at a CAGR of around 13% for the period 2019-2023, driven by the increasing incidence of breast cancer, growing popularity of digital breast tomosynthesis and consistent launch of new products.

These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

Breast cancer has become one of the most common malignancies in women across the world and accounts for the second-largest number of diagnosed cases. More...
Additionally, the associated risk factors for breast cancer are also on the rise. Factors such as lack of physical activity, poor dietary habits, tobacco use, alcohol consumption, and high body mass index are contributing to the rise in cancer incidence. Hence, the increasing incidence of breast cancer is boosting the demand for digital breast tomosynthesis and in turn, fueling the growth of the market.

Based on product, the 2D/3D combination systems segment is expected to account for the highest share in the digital breast tomosynthesis market. The use of computer-aided detection (CAD) for digital breast tomosynthesis is one of the major trends being witnessed in the market. CAD systems are playing an increasingly pivotal role in the interpretation of digital breast tomosynthesis images, aiding clinicians in detecting lesions with higher efficiency and effectiveness. CAD has the potential to increase cancer detection rates, reduce the 3D tomosynthesis interpretation time and optimize reading workflow, and reduce false-positive rates. The use of CAD systems is helping to overcome some of the limitations of the existing digital breast tomosynthesis.

Geographically, the Americas held the largest market share of more than 74% in 2018, followed by the EMEA and APAC. The Americas is expected to continue dominating the digital breast tomosynthesis market during the forecast period with the highest incremental growth.

Related Links:
Technavio Research


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Imaging Table
Stille imagiQ2
Medical Monitor
VITALMAX 4100SL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.